← Back to guidelines
Cardiology2 papers

Dilatation of fetal renal pelvis

Last edited: 4/23/2026

Overview

Fetal renal pelvis dilatation refers to an abnormal widening of the renal pelvis in utero, often indicative of obstructive uropathy or other renal anomalies 1.

Diagnosis

  • Key Diagnostic Criteria: Anteroposterior diameter of the renal pelvis greater than 5 mm 1.
  • Recommended Tests: Color flow Doppler imaging for assessing renal artery flow velocity waveforms 1.
  • Limitations: Color flow Doppler is not useful for differentiating causes of fetal renal dilation due to unchanged pulsatility index in affected cases 1.
  • Management

  • First-Line Treatments: No specific pharmacological treatments mentioned; management often focuses on monitoring and timing of delivery 1.
  • Adjunctive Measures: Close fetal surveillance including serial ultrasounds to monitor progression 1.
  • Special Populations

  • Pregnancy: Focus on prenatal monitoring and potential need for early delivery if obstruction is severe 1.
  • Key Recommendations

  • Utilize color flow Doppler imaging cautiously as it does not reliably differentiate between causes of fetal renal dilation (Evidence: Weak) 1.
  • Monitor fetuses with renal pelvis dilatation closely with serial ultrasounds to assess progression and need for intervention (Evidence: Expert opinion) 1.
  • Consider early delivery if severe obstruction is suspected based on clinical progression and imaging findings (Evidence: Expert opinion) 1.
  • References

    1 Bates JA, Irving HC. Inability of color and spectral Doppler to identify fetal renal obstruction. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1992. link

    Original source

    1. [1]
      Inability of color and spectral Doppler to identify fetal renal obstruction.Bates JA, Irving HC Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG